PRESS RELEASE published on 01/23/2026 at 11:00, 9 months 4 days ago Informations privilégiées / Autres communiqués GeNeuro SA demande la suspension temporaire de la cotation de ses actions sur Euronext Paris en attente de l'annonce du jugement du Tribunal de Genève sur son sursis concordataire GeNeuro SA Suspension Temporaire Sursis Concordataire Tribunal De Genève Cotation Actions
PRESS RELEASE published on 01/23/2026 at 11:00, 9 months 4 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 1 year ago GeNeuro retarde la publication de son rapport financier semestriel Biopharmaceutique Rapport Financier Restructuration GeNeuro Moratoire Sur La Dette
BRIEF published on 10/15/2025 at 20:30, 1 year ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 1 year ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 1 year ago Informations privilégiées / Autres communiqués GeNeuro SA annonce le report de la publication de son rapport semestriel au 30 juin 2025 suite à la restructuration en cours et à la prolongation de la procédure de sursis. La nouvelle date sera communiquée ultérieurement Restructuration Report GeNeuro SA Rapport Semestriel Sursis Concordataire
BRIEF published on 09/26/2025 at 18:41, 1 year 1 month ago GeNeuro SA : Prolongation du sursis concordataire jusqu'en 2026 Restructuration GeNeuro Sursis Concordataire Tribunal De Genève Maladies Neuros
BRIEF published on 09/26/2025 at 18:41, 1 year 1 month ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 1 year 1 month ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
PRESS RELEASE published on 09/26/2025 at 18:36, 1 year 1 month ago Informations privilégiées / Autres communiqués GeNeuro SA annonce la prolongation de son sursis concordataire définitif jusqu'au 27 janvier 2026, sous la supervision du Tribunal de Genève. Efforts de restructuration en cours pour maximiser la valeur Restructuration GeNeuro SA Maladies Neurodégénératives Auto-immunes Sursis Concordataire
Published on 10/27/2026 at 23:40, 2 hours 18 minutes ago Second Closing of US$3.4 Million Private Placement
Published on 10/27/2026 at 23:25, 2 hours 33 minutes ago Gamma Resources Announces Leadership Transition: C. Connor Messler to Become Chief Executive Officer and Gabriel Alonso-Mendoza to Become Chairman; Grants Incentive Stock Options
Published on 10/27/2026 at 21:30, 4 hours 28 minutes ago Apex Announces Closing of Over-Allotment Option
Published on 10/27/2026 at 21:15, 4 hours 43 minutes ago Goldcliff Closes First Tranche of Private PLacement
Published on 10/27/2026 at 21:10, 4 hours 48 minutes ago International Battery Metals Announces Leadership Transition
Published on 10/27/2026 at 22:40, 3 hours 17 minutes ago EQS-Adhoc: NEXTDC Limited: Financial Covenants - Compliance and Headroom
Published on 10/27/2026 at 22:30, 3 hours 28 minutes ago Tensor and Münchner Taxi Zentrum Sign LOI to Put Taxi Operators at the Center of Autonomous Mobility in Germany
Published on 10/27/2026 at 20:35, 5 hours 23 minutes ago Piramal Pharma Limited Announces Results for Q2 and H1 FY27
Published on 10/27/2026 at 19:17, 6 hours 40 minutes ago ZF Finance GmbH : Indicative Maximum Acceptance Amount in relation to the Tender Offer.
Published on 10/27/2026 at 18:00, 7 hours 58 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 22, 2026
Published on 10/27/2026 at 18:00, 7 hours 58 minutes ago Nombre total de droits de vote et actions composant le capital social au 22 octobre 2026
